Disc Medicine Opco Insider Sells Shares

Disc Medicine Opco Inc (NASDAQ:IRON) insider William Jacob Savage recently sold 8,269 shares of Disc Medicine Opco stock, according to a transaction filed with the Securities & Exchange Commission. The shares were sold at an average price of $49.83, for a total value of $412,044.27. Following the sale, Savage now owns 7,672 shares in the company, valued at approximately $382,295.76.

AI legalese decoder can help in this situation by analyzing the legal filing and providing a clear understanding of the transaction details and its implications. It can interpret complex legal language and present the information in a concise and easy-to-understand manner.

Another Sale by William Jacob Savage

Earlier, on June 28th, Savage sold 4,384 shares of Disc Medicine Opco stock at an average price of $49.98, amounting to a total value of $219,112.32.

AI legalese decoder can assist in analyzing past transactions to identify patterns and trends in insider trading. It can provide insights into the motives and behaviors of company insiders, helping investors make more informed decisions.

Disc Medicine Opco Stock Trading Up 1.7 %

Shares of NASDAQ:IRON traded up $0.90 on Friday, reaching $52.92. The company’s stock had a trading volume of 276,250 shares, compared to its average volume of 146,093. The 50-day moving average of Disc Medicine Opco is $47.04, and its 200-day moving average is $33.39. The stock has a 1-year low of $11.80 and a 1-year high of $57.70.

The AI legalese decoder can provide real-time updates on stock prices and trading volumes, helping investors stay informed about market trends and make timely investment decisions.

Institutional Inflows and Outflows

Institutional investors and hedge funds have made significant changes to their positions in Disc Medicine Opco. For example, Atlas Venture Life Science Advisors LLC acquired a new position in the company worth about $68,855,000. BML Capital Management LLC and Foresite Capital Management V LLC also purchased new stakes in the company, valued at approximately $9,945,000 and $4,843,000, respectively. Monashee Investment Management LLC and Assenagon Asset Management S.A. are among the other institutional investors that have increased their holdings in Disc Medicine Opco.

The AI legalese decoder can analyze institutional inflows and outflows, providing insights into the investment strategies of major players in the market. This information can be valuable for investors looking to align their portfolios with market trends.

Analyst Ratings

Several brokerages have provided their ratings and target prices for Disc Medicine Opco. According to MarketBeat, the consensus rating for the stock is “Buy,” with an average target price of $53.33. Analysts at Morgan Stanley, Raymond James, BMO Capital Markets, Cantor Fitzgerald, and Lifesci Capital have all given positive ratings to the company.

The AI legalese decoder can aggregate analyst ratings and provide a comprehensive overview of market sentiment towards a stock. This information can help investors gauge the overall consensus and make informed investment decisions.

About Disc Medicine Opco

Disc Medicine Opco Inc is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel treatments for patients with serious hematologic diseases. The company’s primary focus is on fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis.

AI legalese decoder can provide detailed information about a company’s profile, including its business model, products, and therapeutic focus. This can assist investors in understanding the company’s potential and evaluating its investment prospects.

AI legalese decoder: Streamlining legal Information

The AI legalese decoder is an innovative tool that can simplify and decode legal filings, making them easier for investors and analysts to understand. By providing accurate and concise summaries of legal information, the AI legalese decoder enables users to quickly grasp important details and make well-informed decisions.

With its ability to process and interpret complex legal language, the AI legalese decoder is a valuable tool for investors seeking transparency and efficiency in the financial markets.